Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
5 New strategies for drug development The emergence of resistance from the prolonged or monotherapeutic use of traditional antifungal agents, combined with the low success rate of new drug development, continues to hinder effective treatment of clinical fungal infections
Phase 2 clinical trials have demonstrated its long-term safety and efficacy
and Novartiss Entresto, a $7.8 billion heart failure drug facing generic competition as early as mid-2025
It is not a stand-alone fat burner and should not be expected to create significant changes in isolation
They are primarily used for weight management in individuals with obesity or overweight and for the treatment of type 2 diabetes
An unregulated supply chain can result in the production of fraudulent products, medication containing incorrect ingredients, or products with either too high or too low potency, leading to inconsistent results and danger
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
